A user experiencing the early stages of a CJC-1295 (No DAC) regimen reported developing headaches within the first five days. At the time of the report, no positive benefits had yet been observed.
A user experiencing the early stages of a CJC-1295 (No DAC) regimen reported developing headaches within the first five days. At the time of the report, no positive benefits had yet been observed.